Data Transfer Agreement Clinical Trial Template for Indonesia

Generate a bespoke document

Trusted by 200k+ teams

4.7 Capterra
4.8 Product Hunt
4.6 Trustpilot

What is a Data Transfer Agreement Clinical Trial?

The Data Transfer Agreement Clinical Trial is essential for organizations conducting clinical trials in Indonesia where patient data needs to be shared between different entities. This document is specifically designed to comply with Indonesian regulatory requirements, including the Personal Data Protection Law, Health Law, and clinical trial regulations. It should be used whenever clinical trial data, including patient information, research results, and trial outcomes, needs to be transferred between parties such as research institutions, pharmaceutical companies, hospitals, or contract research organizations. The agreement covers crucial aspects such as data security measures, privacy protection, regulatory compliance, breach notification procedures, and specific requirements for handling sensitive medical data in the Indonesian jurisdiction. It also addresses cross-border data transfer requirements when applicable and ensures alignment with international clinical trial standards while maintaining compliance with local regulations.

Reviewed by

Swetha Meenal

Legal Engineer, GenieAI

Swetha Meenal profile photo

A lawyer, legal researcher and legal tech founder, Swetha has built AI products deployed inside Tier 1 firms and enterprises. She ensures GenieAI's alignment with the latest regulation and executes testing on the legal robustness of Genie output.

Reviewed by

Imad Mohammed Nazar

Legal Engineer, GenieAI

Imad Mohammed Nazar profile photo

A Skadden-trained M&A lawyer, Imad advised on cross-border transactions and contractual risk before moving into legal AI. He reviews GenieAI's output for compliance and enforceability across our 150+ supported jurisdictions, as well as facilitating external benchmarking.

Jurisdiction

Indonesia

Publisher

GenieAI

Sector

Business

Cost

Free to use

Last updated

About the Data Transfer Agreement Clinical Trial

A Data Transfer Agreement Clinical Trial is a specialized legal contract that governs the secure exchange of clinical trial data between different organizations in Indonesia. This document ensures compliance with Indonesia's Personal Data Protection Law, ITE regulations, and clinical trial requirements while protecting sensitive patient information and research data. You'll need this agreement whenever clinical trial data must be shared between parties such as research institutions, pharmaceutical companies, hospitals, contract research organizations, or international partners.

When do you need this document?

You require a Data Transfer Agreement Clinical Trial when conducting multi-site clinical studies involving multiple organizations, transferring patient data to contract research organizations for analysis, sharing trial results with pharmaceutical sponsors, or collaborating with international research partners. This agreement is essential when hospitals transfer patient data to academic medical centers, when data processing centers handle clinical trial information, or when laboratory results need to be shared between clinical trial sites. Indonesian law requires explicit agreements for any transfer of personal health data, making this document mandatory for legitimate clinical research activities.

Key legal considerations

The agreement must clearly define data ownership, processing limitations, and security obligations for both parties. Critical clauses include data minimization principles ensuring only necessary information is transferred, retention periods specifying how long data can be stored, and deletion requirements for data destruction after the trial concludes. You must address breach notification procedures, liability allocation, and compliance monitoring mechanisms. The contract should specify permitted uses of the data, restrictions on further transfers, and requirements for obtaining patient consent. Security measures including encryption, access controls, and audit trails must be detailed to protect sensitive clinical information.

Legal requirements in Indonesia

Indonesian law requires strict compliance with the Personal Data Protection Law, which mandates explicit consent for processing sensitive health data and imposes significant penalties for violations. The ITE Law governs electronic data transfers and requires valid digital signatures for certain agreements. Minister of Health Regulation No. 39 of 2013 establishes specific requirements for clinical trial data management, including confidentiality obligations and data integrity standards. You must ensure the agreement addresses cross-border transfer restrictions if data leaves Indonesia, comply with National Agency of Drug and Food Control regulations, and maintain documentation demonstrating lawful basis for data processing. The contract must specify Indonesian governing law and jurisdiction for dispute resolution, ensuring enforceability under local legal frameworks.

GOVERNING LAW

Applicable law

This Data Transfer Agreement Clinical Trial is drafted to comply with Indonesia law. Key legislation includes:

Genie's Security Promise

Genie is the safest place to draft. Here's how we prioritise your privacy and security.

Your data is private:

We do not train on your data; Genie's AI improves independently

All data stored on Genie is private to your organisation

Your documents are protected:

Your documents are protected by ultra-secure 256-bit encryption

We are ISO27001 certified, so your data is secure

Organizational security:

You retain IP ownership of your documents and their information

You have full control over your data and who gets to see it